|
NGRN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.69320000000095E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.415300E-04 |
| Normal-vs-Stage2 |
5.407600E-01 |
| Normal-vs-Stage3 |
2.26009999999555E-05 |
| Normal-vs-Stage4 |
6.94479995733133E-09 |
| Stage1-vs-Stage2 |
4.375900E-04 |
| Stage1-vs-Stage3 |
1.163000E-01 |
| Stage1-vs-Stage4 |
5.048600E-04 |
| Stage2-vs-Stage3 |
1.644550E-04 |
| Stage2-vs-Stage4 |
1.06649999997988E-06 |
| Stage3-vs-Stage4 |
7.419600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.26729999999831E-06 |
| Normal-vs-AfricanAmerican |
6.898300E-03 |
| Normal-vs-Asian |
1.428890E-04 |
| Caucasian-vs-AfricanAmerican |
9.306200E-01 |
| Caucasian-vs-Asian |
8.310400E-01 |
| AfricanAmerican-vs-Asian |
8.264000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.042900E-04 |
| Normal-vs-Female |
1.584890E-04 |
| Male-vs-Female |
4.525800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.16140000000631E-05 |
| Normal-vs-Age(41-60Yrs) |
9.204200E-04 |
| Normal-vs-Age(61-80Yrs) |
7.717300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.607800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.042600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.936600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.170800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.273200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.954200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.438200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.73269999979165E-07 |
| Classical-VS-Follicular |
4.53479999995565E-06 |
| Classical-VS-Other |
9.627000E-01 |
| Classical-VS-Normal |
1.60359999999971E-05 |
| Tall-VS-Follicular |
5.69710945086399E-12 |
| Tall-VS-Other |
2.654400E-01 |
| Tall-VS-Normal |
1.13309361893243E-12 |
| Follicular-VS-Other |
1.535000E-01 |
| Follicular-VS-Normal |
5.520000E-01 |
| Other-VS-Normal |
2.232600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.250200E-02 |
| Normal-vs-N1 |
6.81730005780423E-10 |
| N0-vs-N1 |
8.61810000030161E-08 |
|
|
